Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Rectal Carcinoma”

664 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 664 results

Testing effectiveness (Phase 2)Study completedNCT00807911
What this trial is testing

Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

Who this might be right for
Rectal Cancer
Asan Medical Center 322
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00427713
What this trial is testing

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Research UK 800
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521605
What this trial is testing

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Who this might be right for
Rectal Cancer Patients
Guangdong Provincial People's Hospital 44
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Not applicableLooking for participantsNCT06761287
What this trial is testing

Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Centre Hospitalier Universitaire Saint Pierre 20
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Ended earlyNCT02112162
What this trial is testing

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Who this might be right for
Rectal Neoplasms
Washington University School of Medicine 2
Not applicableLooking for participantsNCT03064646
What this trial is testing

Organ Preservation in Locally Advanced Rectal Cancer

Who this might be right for
LOCALLY ADVANCED RECTAL CANCER
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 30
Large-scale testing (Phase 3)Looking for participantsNCT06229041
What this trial is testing

Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 472
Testing effectiveness (Phase 2)Study completedNCT00220051
What this trial is testing

A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer

Who this might be right for
Rectal Cancer
Royal Marsden NHS Foundation Trust 109
Testing effectiveness (Phase 2)Study completedNCT04130854
What this trial is testing

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Locally Advanced Rectal Adenocarcinoma
University of Texas Southwestern Medical Center 58
Not applicableNot Yet RecruitingNCT07080411
What this trial is testing

The Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerAdaptive Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 49
Very early researchActive Not RecruitingNCT06853769
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Testing effectiveness (Phase 2)Study completedNCT00828672
What this trial is testing

Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Universitaire Ziekenhuizen KU Leuven 84
Early research (Phase 1)Study completedNCT00084643
What this trial is testing

GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIC Colon Cancer+6 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00084591
What this trial is testing

Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003950
What this trial is testing

Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 16
Next Page